AVENTIS PASTEUR

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C07G COMPOUNDS OF UNKNOWN CONSTITUTION 19
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7094408 Immunogenicity using a combination of DNA and vaccinia virus vector vaccinesApr 30, 01Aug 22, 06[A61K]
7018637 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccinesFeb 23, 98Mar 28, 06[A61K]
6933137 Animal component free meningococcal polysaccharide fermentation and seedbank developmentMay 16, 03Aug 23, 05[C12P, C12N]
6309647 Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinantsJul 15, 99Oct 30, 01[A61K, C12N]
6146902 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutionsDec 29, 98Nov 14, 00[A61K, C07G, G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8309100 genus pathogenic strainsExpiredFeb 04, 10Nov 13, 12[A61K, C07H, C12P]
2011/0319,480 Method of Inducing and/or Enhancing an Immune Response to Tumor AntigensAbandonedAug 02, 11Dec 29, 11[A61K, C12N, A61P]
7704513 genusExpiredMar 27, 08Apr 27, 10[A61K, C07H, C12P]
2009/0156,519 Modified KSA and Uses ThereofAbandonedDec 23, 04Jun 18, 09[A61K, C12N, A61P]
7384768 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genusExpiredAug 03, 04Jun 10, 08[]
2006/0002,946 Targeted immunogensAbandonedDec 30, 04Jan 05, 06[C07H, A61K, C07K]
6890711 Titration method for a complex viral compositionExpiredApr 03, 98May 10, 05[G01N]
2005/0002,948 Method of enhanced immunogenicity to meningococcal vaccinationAbandonedMay 07, 04Jan 06, 05[A61K]
2005/0002,957 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccineAbandonedMay 07, 04Jan 06, 05[A61K, C07K]
6835384 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strainsExpiredAug 16, 01Dec 28, 04[A61K, C12P, C12N, C07K]
2004/0170,646 Production of ALVAC on avian embryonic stem cellsAbandonedDec 12, 03Sep 02, 04[A61K, C12N]
6780407 Pox virus comprising DNA sequences encoding CEA and B7 antigenExpiredSep 15, 00Aug 24, 04[A61K, A01N, C12N]
6780421 Adjuvant for a vaccine compositionExpiredSep 09, 97Aug 24, 04[A61K]
2004/0132,676 Polynucleotide formulation for enhanced intracellular transferAbandonedMar 17, 04Jul 08, 04[A61K]
2004/0038,922 Vaccine compositionAbandonedApr 04, 03Feb 26, 04[A61K]
2004/0033,545 Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigensAbandonedOct 15, 02Feb 19, 04[G01N]
6538123 Vaccine composition for preventing or treating hepatitis CExpiredJul 26, 01Mar 25, 03[C07H]
2003/0035,806 Novel meningitis conjugate vaccineAbandonedMay 09, 02Feb 20, 03[A61K]
6465171 CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contaminationExpiredJun 14, 00Oct 15, 02[C12Q, C12P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.